Ayako Nakashoji

5PUBLICATIONS
22CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 27, 2025
MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer.

Shinkichi Takamori, Naoki Haratake, Atrayee Bhattacharya

|Aug 08, 2025
Activation of APOBEC3 cytidine deaminases and endogenous retroviruses is integrated by MUC1-C in NSCLC cells.

Naoki Haratake, Shinkichi Takamori, Hideko Isozaki

|Apr 15, 2024
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.

Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya

|Jul 21, 2021
Chemotherapy resumption in breast cancer patient after COVID-19.

Julian Horiguchi, Ayako Nakashoji, Naoki Kawahara

Pageof 1